These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 16804877

  • 1. Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.
    Yamamoto N, Nakagawa K, Uejima H, Sugiura T, Takada Y, Negoro S, Matsui K, Kashii T, Takada M, Nakanishi Y, Kato T, Fukuoka M, West Japan Thoracic Oncology Group (WJTOG).
    Cancer; 2006 Aug 01; 107(3):599-605. PubMed ID: 16804877
    [Abstract] [Full Text] [Related]

  • 2. Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004.
    Saito H, Nakagawa K, Takeda K, Iwamoto Y, Ando M, Maeda M, Katakami N, Nakano T, Kurata T, Fukuoka M.
    Am J Clin Oncol; 2012 Feb 01; 35(1):58-63. PubMed ID: 21293243
    [Abstract] [Full Text] [Related]

  • 3. Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.
    Laack E, Dickgreber N, Müller T, Knuth A, Benk J, Lorenz C, Gieseler F, Dürk H, Engel-Riedel W, Dalhoff K, Kortsik C, Graeven U, Burk M, Dierlamm T, Welte T, Burkholder I, Edler L, Hossfeld DK, German and Swiss Lung Cancer Study Group.
    J Clin Oncol; 2004 Jun 15; 22(12):2348-56. PubMed ID: 15197195
    [Abstract] [Full Text] [Related]

  • 4. A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC).
    Grigorescu A, Ciuleanu T, Firoiu E, Muresan DR, Teodorescu G, Basson BR.
    Lung Cancer; 2007 Aug 15; 57(2):168-74. PubMed ID: 17467848
    [Abstract] [Full Text] [Related]

  • 5. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
    Greco FA, Gray JR, Thompson DS, Burris HA, Erland JB, Barton JH, Litchy S, Houston GA, Butts JA, Webb C, Scott C, Hainsworth JD.
    Cancer; 2002 Sep 15; 95(6):1279-85. PubMed ID: 12216096
    [Abstract] [Full Text] [Related]

  • 6. Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
    Danson S, Middleton MR, O'Byrne KJ, Clemons M, Ranson M, Hassan J, Anderson H, Burt PA, Fairve-Finn C, Stout R, Dowd I, Ashcroft L, Beresford C, Thatcher N.
    Cancer; 2003 Aug 01; 98(3):542-53. PubMed ID: 12879472
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.
    Alberola V, Camps C, Provencio M, Isla D, Rosell R, Vadell C, Bover I, Ruiz-Casado A, Azagra P, Jiménez U, González-Larriba JL, Diz P, Cardenal F, Artal A, Carrato A, Morales S, Sanchez JJ, de las Peñas R, Felip E, López-Vivanco G, Spanish Lung Cancer Group.
    J Clin Oncol; 2003 Sep 01; 21(17):3207-13. PubMed ID: 12947054
    [Abstract] [Full Text] [Related]

  • 8. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.
    Han JY, Lee DH, Song JE, Lee SY, Kim HY, Kim HT, Lee JS.
    Cancer; 2008 Jul 15; 113(2):388-95. PubMed ID: 18484595
    [Abstract] [Full Text] [Related]

  • 9. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Herbst RS, Khuri FR, Lu C, Liu DD, Fossella FV, Glisson BS, Pisters KM, Shin DM, Papadimitrakopoulou VA, Kurie JM, Blumenschein G, Kies MS, Zinner R, Jung MS, Lu R, Lee JJ, Munden RF, Hong WK, Lee JS.
    Cancer; 2002 Jul 15; 95(2):340-53. PubMed ID: 12124835
    [Abstract] [Full Text] [Related]

  • 10. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V, Galetta D, Caruso M, Verderame F, Pezzella G, Valdesi M, Borsellino N, Pandolfo G, Durini E, Rinaldi M, Loizzi M, Gebbia N, Valenza R, Tirrito ML, Varvara F, Colucci G, Gruppo Ocologico Italia Meridionale.
    Lung Cancer; 2003 Feb 15; 39(2):179-89. PubMed ID: 12581571
    [Abstract] [Full Text] [Related]

  • 11. Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie).
    Thomas P, Robinet G, Gouva S, Fournel P, Léna H, Le Caer H, Perol M, Berard H, Bombaron P, Vergnenegre A, Kleisbauer JP, Groupe français de pneumo-cancérologie.
    Lung Cancer; 2006 Jan 15; 51(1):105-14. PubMed ID: 16310886
    [Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy of gemcitabine and vinorelbine for patients in stage IIIB-IV non-small cell lung cancer: a phase II study of the West Japan Thoracic Oncology Group (WJTOG) 9908.
    Katakami N, Sugiura T, Nogami T, Yamamoto H, Negoro S, Nakano T, Okamoto N, Takada Y, Kodama K, Ariyoshi Y.
    Lung Cancer; 2004 Jan 15; 43(1):93-100. PubMed ID: 14698543
    [Abstract] [Full Text] [Related]

  • 13. Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.
    Helbekkmo N, Sundstrøm SH, Aasebø U, Brunsvig PF, von Plessen C, Hjelde HH, Garpestad OK, Bailey A, Bremnes RM, Norwegian Lung Cancer Study Group.
    Br J Cancer; 2007 Aug 06; 97(3):283-9. PubMed ID: 17595658
    [Abstract] [Full Text] [Related]

  • 14. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A, Liptay M, LaCombe M, Marymont M, Kies MS, Sundaresan S, Masters G.
    Lung Cancer; 2004 Aug 06; 45(2):243-53. PubMed ID: 15246197
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.
    Greco FA, Spigel DR, Kuzur ME, Shipley D, Gray JR, Thompson DS, Burris HA, Yardley DA, Pati A, Webb CD, Gandhi JG, Hainsworth JD.
    Clin Lung Cancer; 2007 Sep 06; 8(8):483-7. PubMed ID: 17922972
    [Abstract] [Full Text] [Related]

  • 16. A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.
    Heo SJ, Jung I, Lee CK, Kim JH, Lim SM, Moon YW, Shim HS, Jeong J, Kim JH, Kim HR, Cho BC.
    Cancer Chemother Pharmacol; 2016 Mar 06; 77(3):539-48. PubMed ID: 26811178
    [Abstract] [Full Text] [Related]

  • 17. Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.
    Pallis AG, Syrigos K, Kotsakis A, Karachaliou N, Polyzos A, Chandrinos V, Varthalitis I, Christophyllakis C, Ardavanis A, Vamvakas L, Vardakis N, Saridaki Z, Samonis G, Giassas S, Georgoulias V, Agelaki S.
    Clin Lung Cancer; 2011 Mar 06; 12(2):100-5. PubMed ID: 21550556
    [Abstract] [Full Text] [Related]

  • 18. A randomized study of gemcitabine plus cisplatin and vinorelbine plus cisplatin in patients with advanced non-small-cell lung cancer.
    Chang JW, Tsao TC, Yang CT, Lin MC, Cheung YC, Liaw CC, Chen CH.
    Chang Gung Med J; 2008 Mar 06; 31(6):559-66. PubMed ID: 19241895
    [Abstract] [Full Text] [Related]

  • 19. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.
    Kubota K, Kawahara M, Ogawara M, Nishiwaki Y, Komuta K, Minato K, Fujita Y, Teramukai S, Fukushima M, Furuse K, Japan Multi-National Trial Organisation.
    Lancet Oncol; 2008 Dec 06; 9(12):1135-42. PubMed ID: 19013107
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
    Comella P, Frasci G, Panza N, Manzione L, Lorusso V, Di Rienzo G, Cioffi R, De Cataldis G, Maiorino L, Bilancia D, Nicolella G, Natale M, Carpagnano F, Pacilio C, De Lena M, Bianco A, Comella G.
    J Clin Oncol; 1999 May 06; 17(5):1526-34. PubMed ID: 10334540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.